Strides puts best biopharma foot forward into Malaysia
This article was originally published in Scrip
Executive Summary
Malaysia continues to draw Indian pharma manufacturing interest, offering attractive tax breaks and a well-developed infrastructure to companies wanting to develop their business in the Asian region. Strides Arocolab is the latest Indian firm to unveil plans to set up a biopharmaceuticals unit in the Malaysian biotech park, Bio-XCell.